VAXCHORA is a prescription vaccine used in children and adults for a disease called cholera. You take VAXCHORA by mouth to help protect you against the type of cholera caused by the bacteria Vibrio cholerae serogroup O1.
VAXCHORA should only be used by certain people. You should only take VAXCHORA if you are between 2 and 64 years old and plan to travel to places where cholera is present.
VAXCHORA may not work for:
It is not known if VAXCHORA is safe and effective in children under 2 years old.
Do not use VAXCHORA if you are allergic to any ingredient of VAXCHORA or have had an allergic reaction to any cholera vaccine.
It is important to tell your healthcare provider (HCP) if:
VAXCHORA was not studied in people with a weakened immune system. The vaccine may not protect these people.
Tell your HCP about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Taking VAXCHORA and certain other medicines may affect how VAXCHORA works and may cause
After taking VAXCHORA, adults (18-45 years old) may experience tiredness, headache, stomach pain, nausea, vomiting, loss of appetite, and diarrhea. Children and adolescents (2-17) may experience headache, tiredness, stomach pain, loss of appetite, and nausea.
This summary provides basic information about VAXCHORA, but it does not include all information known about this vaccine. Talk to your HCP or pharmacist about this information. Your HCP is the best person to help you decide if VAXCHORA is right for you.
VAX CON ISI 01/2021
For more information about VAXCHORA, please see full Prescribing Information.
Emergent BioSolutions®, Protected by Emergent BioSolutions®, VAXCHORA® and any and all Emergent BioSolutions Inc. brands, products, services and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. All other brands, products, services and feature names or trademarks are the property of their respective owners.
© 2023 Emergent BioSolutions Inc. All rights reserved.
PP-VAX-US-00018 | January 2023